QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
The updated guideline on managing cancer-related fatigue (CRF) in adult survivors of cancer recommends evidence- based interventions. A panel of experts conducted a review of 113 randomized controlled trials (RCTs) from 2013 to 2023. Key findings include: • Effective interventions…
Obesity, linked to both prostate cancer death and overall mortality, is influenced by a high-fat diet. While a high-fat diet is known to contribute to obesity, its role in prostate cancer metastasis is unclear. In this study, researchers tested the…
Research from The Institute of Cancer Research, London, suggests that the drug NXP800, currently in clinical trials for ovarian and bile duct cancer, may offer a new treatment option for prostate cancer resistant to hormone therapy. While hormone therapies like…
On November 7-10, 2024, while attending the Annual Meeting of the Clinical Association of Genitourinary Surgeons at Stanford University, hosted by Stanford’s Chair of Urology, Dr. Eila Skinner, Dr. Catalona was inspired by a presentation given by Nobel Prize Laureate,…
In the Summer/Fall QUEST, our readers were introduced to a rising star in the opera firmament:Benjamin R. Sokol. This year, 2024, has been an exciting one for Benjamin as he was named a winner of the 2024 Opera Index Competition…
A new survey finds that the majority of American men have incorrect beliefs regarding prostate cancer screening which could keep them from getting screened. In August, the American Cancer Society and the Harris Poll surveyed 1,200 US men ages 45…
This study looked at the effectiveness and safety of using MRI screening to detect prostate cancer in men aged 50-60. Researchers divided participants into two groups: one had systematic biopsies (where the prostate gland is charted into six regions and…
A recent article published in the Journal of the American Medical Association, Oncology (JAMA Oncol) included a report on the role of diet in men with low-risk prostate cancer. Dr. Stephen DeVries, a preventive cardiologist and Executive Director of the…
The study investigated how body mass index (BMI) relates to prostate cancer screening results, incidence, and mortality among men participating in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. This trial included 36,756 men who were regularly screened…
A recent clinical trial at Memorial Sloan Kettering Cancer Center in New York suggests that specific amounts of exercise before surgery among men with early-stage prostate cancer can improve two biomarkers associated with better outcomes. This study looked at…
"*" indicates required fields
